Title: Influence of Renal Function on Outcome of VAD or Bortezomib, Doxorubicin , Dexamethasone (PAD) Induction Treatment Followed by High-Dose Melphalan (HDM): A Subgroup Analysis From the HOVON-65/GMMG-HD4 Randomized Phase III Trial for Newly Diagnosed Multiple Myeloma
Authors: Scheid, Christof
Sonneveld, Pieter
Schmidt-Wolf, Ingo
van der Holt, Bronno
Hielscher, Thomas
el Jarari, Laila
Bertsch, Uta
Salwender, Hans
Zweegman, Sonja
Haenel, Mathias
Vellenga, Edo
Schubert, Joerg
Blau, Igor Wolfgang
Jie, Asiong
van de Velde, Helgi
Peter, Norma
Schaafsma, Martijn
Lindemann, Walter
Kersten, Marie Jose
Duehrsen, Ulrich
Delforge, Michel
Weisel, Katja
Croockewit, Sandra
Martin, Hans
Wittebol, Shularmit
Schouten, Harry
van Marwijk-Kooy, Marinus
Wijermans, Pierre
Lokhorst, Henk M
Goldschmidt, Hartmut #
Issue Date: Nov-2010
Publisher: Amer soc hematology
Host Document: Blood vol:116 issue:21 pages:993-994
Conference: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) Orlando, FL, DEC 04-07, 2010
ISSN: 0006-4971
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Embryo and Stemcells (-)
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.